- Home
- ETON vs NUS Comparison
ETON vs NUS Comparison
Compare ETON & NUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ETON
- NUS
- Stock Information
- Founded
- ETON 2017
- NUS 1984
- Country
- ETON United States
- NUS United States
- Employees
- ETON N/A
- NUS 15200
- Industry
- ETON Biotechnology: Pharmaceutical Preparations
- NUS Other Pharmaceuticals
- Sector
- ETON Health Care
- NUS Health Care
- Exchange
- ETON Nasdaq
- NUS Nasdaq
- Market Cap
- ETON 329.8M
- NUS 348.5M
- IPO Year
- ETON 2018
- NUS 1996
- Fundamental
- Price
- ETON $14.41
- NUS $7.00
- Analyst Decision
- ETON Strong Buy
- NUS Hold
- Analyst Count
- ETON 3
- NUS 2
- Target Price
- ETON $18.67
- NUS $6.88
- AVG Volume (30 Days)
- ETON 243.0K
- NUS 922.8K
- Earning Date
- ETON 03-13-2025
- NUS 02-13-2025
- Dividend Yield
- ETON N/A
- NUS 3.42%
- EPS Growth
- ETON N/A
- NUS N/A
- EPS
- ETON N/A
- NUS N/A
- Revenue
- ETON $34,677,000.00
- NUS $1,775,172,000.00
- Revenue This Year
- ETON $22.25
- NUS N/A
- Revenue Next Year
- ETON $81.48
- NUS N/A
- P/E Ratio
- ETON N/A
- NUS N/A
- Revenue Growth
- ETON 5.64
- NUS N/A
- 52 Week Low
- ETON $3.03
- NUS $5.95
- 52 Week High
- ETON $15.00
- NUS $19.30
- Technical
- Relative Strength Index (RSI)
- ETON 62.22
- NUS 50.87
- Support Level
- ETON $13.09
- NUS $6.77
- Resistance Level
- ETON $14.35
- NUS $7.15
- Average True Range (ATR)
- ETON 1.13
- NUS 0.43
- MACD
- ETON 0.08
- NUS 0.03
- Stochastic Oscillator
- ETON 82.60
- NUS 39.60
About ETON Eton Pharmaceuticals Inc.
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.
About NUS Nu Skin Enterprises Inc.
Nu Skin Enterprises Inc is a health and beauty direct-selling company. It has two primary product categories: beauty products and wellness products. The company develops and distributes nutritional, weight-management products, and food supplements under the Nu Skin and Pharmanex brands, respectively. The company has operations internationally, in more than 50 countries across the Americas, Europe, and the Asia-Pacific.